Susquehanna International Group
LEXX icon

Susquehanna International Group’s Lexaria Bioscience LEXX Stock Holding History

Susquehanna International Group’s Portfolio LEXX Stock Details LEXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-15,426
Closed -$11.2K – 12531
2023
Q2 		$11.2K Sell
15,426
-52,026
-77% -$67.4K ﹤0.01% 11745
2023
Q1 		$183K Buy
67,452
+1,321
+2% +$3.76K ﹤0.01% 10701
2022
Q4 		$162K Buy
66,131
+26,012
+65% +$62.3K ﹤0.01% 10406
2022
Q3 		$98K Buy
+40,119
New +$114K ﹤0.01% 11725

Other funds holding LEXX

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
ICM
Invenomic Capital Management Boston, Massachusetts $2.18B AUM 0.03% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
TSS
Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
1832 Asset Management
1832 Asset Management Toronto, Ontario, Canada $109B AUM 35.56% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

Susquehanna International Group's LEXX Position: Q3 2023 in Review

Susquehanna International Group sold out of Lexaria Bioscience (LEXX) in Q3 2023, closing a stake of 15,426 shares — an estimated $11.2K sold.

Susquehanna International Group first reported a position in LEXX in Q3 2022 and held it in 4 quarters. The position peaked at $183K in Q1 2023. 15 funds tracked by Wall St. Rank hold LEXX as of Q3 2023.

  • Susquehanna International Group reported no remaining Lexaria Bioscience position as of Q3 2023 after selling out during the quarter.
  • Susquehanna International Group sold 15,426 Lexaria Bioscience shares in Q3 2023, an estimated $11.2K.
  • Susquehanna International Group first reported a position in Lexaria Bioscience in Q3 2022 and held it in 4 quarters.
  • Susquehanna International Group's Lexaria Bioscience position peaked at $183K in Q1 2023.
  • 15 funds tracked by Wall St. Rank held Lexaria Bioscience as of Q3 2023.

Based on Susquehanna International Group's 13F filing for Q3 2023, filed 14 Nov 2023.